|1.||McQuillan, Geraldine M: 2 articles (04/2004 - 05/2002)|
|2.||Chu, Susan Y: 2 articles (04/2004 - 05/2002)|
|3.||Shao, Zhujun: 1 article (05/2014)|
|4.||Wang, Haipo: 1 article (05/2014)|
|5.||Gao, Yuan: 1 article (05/2014)|
|6.||Wang, Junsheng: 1 article (05/2014)|
|7.||Zhu, Bingqing: 1 article (05/2014)|
|8.||Zhou, Haijian: 1 article (05/2014)|
|9.||Shi, Zhenhua: 1 article (05/2014)|
|10.||Wu, Yuyan: 1 article (05/2014)|
12/01/1980 - "The intrathecal administration of human tetanus antitoxin as part of treatment appears to be the most effective treatment of tetanus and should be given as soon as the diagnosis of tetanus is established. "
01/01/1989 - "The present study includes 50 cases of tetanus neonatorum who were given 200 IU of tetanus antitoxin (equine) intrathecally once only and 500 IU intravenously daily for 3 consecutive days. "
01/01/1964 - "The authors started a field study in August 1961 with a view to establishing a practicable and effective active immunization schedule to ensure a level of tetanus antitoxin in the pregnant woman sufficient to give protection to newborn babies against tetanus.A fluid and an adsorbed toxoid were used in a total of 377 women. "
03/31/1923 - "STUDIES ON THE RELATION OF TETANUS BACILLI IN THE DIGESTIVE TRACT TO TETANUS ANTITOXIN IN THE BLOOD."
06/01/2012 - "Tetanus immunity determined by seroprevalence of tetanus antitoxin levels exceeded that estimated by vaccination history, and serological markers should be used instead of vaccination history in determining immunity status."
01/01/2003 - "Priming at 2 and 3 1/2 months with diphtheria and tetanus antitoxin, as a component of a DTwP program, and reinforcing 6 months later induced an immune response indicative of protection against the diseases, which persisted up to the age of the booster recommended at school entry."
05/07/2014 - "Interrupted time series analyses examined the changes in antitoxin levels over time and analyzed the alterations in diphtheria and tetanus antitoxin levels after the vaccine switch. "
03/30/2012 - "Protective levels of diphtheria and tetanus antitoxin persisted in 99.3% of adolescents 10 years after a booster dose of Tdap. "
06/01/2006 - "We have compared diphtheria and tetanus antitoxin levels among 13- to 14- and 15- to 16-year-old teenagers to see if the difference was maintained among the older age group. "
04/01/2004 - "Sera from 9411 female participants from the third National Health and Nutrition Examination Survey were tested for diphtheria and tetanus antitoxin. "
|3.||Wounds and Injuries (Trauma)
03/01/2008 - "An emergency doctor sterilized the wound and administered an antibiotic, an analgesic agent and an injection of a tetanus antitoxin. "
04/01/1962 - "Tetanus antitoxin is not given unless contaminated wounds have ben neglected for eight hours or more. "
04/01/1958 - "The use and abuse of tetanus antitoxin in acute injuries."
07/01/1980 - "The frequency of the injections of tetanus antitoxin in connection with wounds decreased from 96% to 39.2%; as a result the consumption of tetanus antitoxin dropped 2.5-fold. "
01/01/1992 - "Tetanus boosters following the primary course but before the present study did not significantly increase the levels of pre-study tetanus antitoxin and following the study booster there was no difference between the preboost levels and the levels on days 1 to 4. This finding indicates that the present recommendations for the use of TIG in tetanus-prone wounds are appropriate."
05/01/1960 - "Serum sickness: serologic studies following prophylactic tetanus antitoxin."
07/01/1967 - "Serum sickness following tetanus antitoxin."
01/01/1958 - "Serum sickness following injection of tetanus antitoxin."
07/01/1954 - "Plasmocytosis in serum sickness from tetanus antitoxin; report of case."
06/29/1964 - "MYOCARDIAL INFARCTION AFTER SERUM SICKNESS FROM TETANUS ANTITOXIN."
01/01/1976 - " Similarly, 74-82% of children 3 months-7 years had tetanus antitoxin levels high enough to avoid infection, as did 80-90% of older children. "
08/01/1979 - "By comparison, these two groups of mice developed about the same tetanus mortality rates, however, following tetanus antitoxin therapy with 3 doses of 100 IU each day on days 0, 4 and 7 after infection, clinical signs of late tetanus exclusively belonged to tumour bearing animals. "
01/01/1984 - "The high prevalence of tetanus provided a unique opportunity to study the potential roles of geophagia, wounding, and clinical tetanus infections on the development of naturally acquired tetanus antitoxin in rhesus macaques. "
06/01/1984 - "[Guinea pig resistance to infection by the spores of the tetanus causative agent at various levels of tetanus antitoxin and delayed hypersensitivity]."
|2.||Immunoglobulin Fab Fragments
|9.||Tetanus Toxoid (Vaccine, Tetanus)